I N T R O D U C T I O N
Acute kidney injury (AKI), characterized by abrupt deterioration in kidney function, is a common condition among hospitalized patients [1] . It often occurs during the course of acute illness (e.g. heart disease and infection) among patients with risk factors such as older age and diabetes [2] . Patients with AKI, especially those with severe AKI requiring acute renal replacement therapy (RRT), have higher short-and long-term mortality rates than those without AKI [1, 3] .
Understanding seasonal patterns of disease is important for clinical practice, hospital resource utilization and preventive care in the community. Several communicable and non-communicable diseases have seasonal variations in their incidence and disease characteristics [4] [5] [6] . For example, heart failure and pneumonia are more common in winter in countries in the northern hemisphere [7, 8] . To our knowledge, however, no published studies have investigated the seasonality of AKI.
Therefore, we explored the seasonal variations in the incidence of AKI among hospitalized patients using a large database of a major Japanese hospital chain. We also examined the association between season and AKI after adjusting for patient characteristics and known risk factors for AKI. Finally, we examined how the disease severity and 30-day mortality of patients with AKI varied across seasons.
M A T E R I A L S A N D M E T H O D S

Data source
We used the Tokushukai Medical Database, a database of a large Japanese hospital chain. For the current study, we retrospectively used the data of 38 hospitals (Supplementary data, Table S1 ) participating in the Diagnosis Procedure Combination system (a Japanese case-mix inpatient classification system [9] ) during the study period of 2012-14. The database includes the following information: patients' age and sex, admission and discharge dates, discharge status (dead or alive), primary admission diagnosis and comorbidities recorded by the attending physician at the time of discharge using International Classification Disease of 10th revision (ICD-10) codes, procedures including chronic and acute RRT, examinations including contrast-enhanced computed tomography (CT) scans, intravenous drugs used, patient-reported medication information recorded at hospital admission, vital signs, and all measured inpatient and outpatient laboratory values. The study was approved by the Tokushukai Group Joint Ethics Committee and conducted in adherence with the tenets of the Declaration of Helsinki. Informed consent from individual patients was waived because all data were anonymized for research purposes.
Study population and definition of AKI
We first identified all hospitalizations of adult patients among the 38 hospitals during the 3 years from January 2012 to December 2014. If a patient was hospitalized multiple times during the study period, we regarded each hospitalization as an independent case. Using the serum creatinine records, we identified patients with AKI based on the Kidney Disease: Improving Global Outcomes (KDIGO) criteria [10] : an increase in the serum creatinine level by !0.3 mg/dL within 48 h during hospitalization or an increase in the serum creatinine level to !1.5 times the baseline level within 7 days. The baseline serum creatinine level was defined as the most recent value recorded in the past 12 months prior to the current hospital admission or, if this was not available, it was calculated by the Modification of Diet in Renal Disease equation for Japanese patients [11] , assuming a glomerular filtration rate (GFR) of 75 mL/min/1.73 m 2 [10] . Once AKI was identified, the AKI stage was determined based on the worst serum creatinine value during hospitalization using the KDIGO criteria [10] : Stage 1, 1.5-1.9 times baseline or a !0.3 mg/dL increase in the serum creatinine; Stage 2, 2.0-2.9 times baseline; and Stage 3, 3.0 times baseline, an increase in serum creatinine to !4.0 mg/dL or initiation of RRT.
Crude incidence of AKI
We plotted the number and proportion of patients with AKI among hospitalized patients by month of hospital admission and identified the months with the highest and lowest proportions of patients with AKI.
We then conducted subgroup analyses based on the following three hypotheses: (i) the seasonality of the AKI incidence is influenced by the seasonality of the primary admission diagnosis in patients with AKI because AKI usually occurs secondary to another acute illness (e.g. heart disease, infection) [12, 13] ; (ii) the seasonality of AKI is mainly driven by the seasonality of community-acquired AKI (i.e. AKI that had already occurred in the community and was diagnosed soon after hospital admission) rather than hospital-acquired AKI (i.e. AKI that occurred during the course of in-hospital care) [14] , because the influence of seasonal changes in weather conditions is seemingly larger outside the hospital; and (iii) older people are more likely to be affected by seasonal fluctuations than younger people because of their decreased physiological adaptability [15, 16] . We thus plotted the monthly number of patients with AKI by (i) the five most common admission diagnosis categories of patients with AKI (cardiovascular disease, pulmonary disease, gastrointestinal disease, genitourinary disease and injury), (ii) the timing of AKI diagnosis (post-admission Day 0, Days 1-6 and Day 7 or later) and (iii) age category (<65, 65-74, 75-84 and !85 years).
Adjusted incidence of AKI
Next, using the data of all hospitalized patients (including those without AKI), we examined the association between season and AKI, adjusting for patient characteristics and known risk factors for AKI. We used generalized linear models for the association between the month of hospital admission (i.e. from January through December for 3 consecutive years) and incidence of AKI, clustering by hospital and adjusting for age, sex, year of admission, comorbidities [hypertension, diabetes mellitus, chronic kidney disease (CKD), liver disease and cancer], admission diagnosis category (cardiovascular disease, pulmonary disease, abdominal disease, genitourinary disease, injury and others), sepsis and use of nephrotoxic substances (contrast agents for CT scans, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, diuretics, non-steroidal antiinflammatory drugs, aminoglycosides, vancomycin, amphotericin B and cisplatin). June was selected as the reference group because it contained the smallest proportion of patients with AKI among hospitalized patients.
Covariates were defined as follows. Hypertension and diabetes were defined according to the ICD-10 codes or patientreported medication information. CKD was defined as a baseline estimated GFR of <60 mL/min/1.73 m 2 . Liver disease and cancer were defined according to the ICD-10 codes. Sepsis was defined as the use of intravenous antibiotics (suggesting a probable or confirmed infection) plus a !2-point increase in the Sequential Organ Failure Assessment score [17] . Sepsis and the use of nephrotoxic substances were defined on the day of or prior to the incidence of AKI for patients with AKI, and anytime during hospitalization for those without AKI.
Disease severity and 30-day mortality of patients with AKI Finally, we assessed seasonal variations in disease severity and 30-day mortality of patients with AKI. The seasons were classified as spring (March-May), summer (June-August), autumn (September-November) and winter (DecemberFebruary). Disease severity was estimated based on the AKI stage and other organ failures. On the day of AKI diagnosis, organ failures were defined in the same way as in a recent large international study on AKI [18] , which referred to the Surviving Sepsis Guidelines 2012 [19] : (i) pulmonary: PaO 2 / FiO 2 ratio of <300 mmHg or use of a mechanical ventilator; (ii) haematological: platelet count of 100 000/lL; (iii) hepatic: serum total bilirubin level of !4.0 mg/dL; (iv) cardiovascular: systolic blood pressure of <90 mmHg, mean arterial pressure of <70 mmHg, systolic blood pressure decrease of >40 mmHg or use of vasoactive drugs (dopamine, dobutamine, noradrenaline or adrenaline); and (v) neurological: altered mental status, defined in this study as a Japanese Coma Scale score of 10 or worse [20] . If the laboratory values and neurological scores were not measured on the day of AKI diagnosis, we used the most recent in-hospital records prior to that date.
We compared the distribution of AKI stages, proportion of patients with each failing organ, total number of failing organs and 30-day mortality across seasons by the chi-squared test. We also conducted unadjusted and adjusted logistic regression analyses for the association between season and failure of each organ system as well as 30-day mortality. We adjusted for age, sex, year of admission, comorbidities, admission diagnosis category, sepsis and use of nephrotoxic substances. For 30-day mortality, we additionally adjusted for each type of organ failure.
The threshold for significance was a P-value of <0.05. All data management and statistical analyses were conducted using STATA version 14 (StataCorp, College Station, TX, USA).
Sensitivity analysis
Determination of patients' baseline kidney function when their previous serum creatinine records are unavailable is controversial [21] [22] [23] . Although we assumed that patients with unavailable previous serum creatinine records had a GFR of 75 mL/min/1.73 m 2 in the main analysis [10] , we performed a sensitivity analysis by assuming that their baseline kidney functions corresponded to their best serum creatinine values during their current hospitalization [23] , and all aforementioned analyses were repeated using this imputation method.
Additional analysis
Using the data of all hospitalized patients (including those without AKI), we also examined the seasonal impact of AKI on 30-day mortality. We estimated the relative risk (AKI versus non-AKI) for 30-day mortality by season in each common admission diagnosis category (cardiovascular disease, pulmonary disease, gastrointestinal disease, genitourinary disease and injury), clustering by hospital and adjusting for age, sex, year of admission, comorbidities, sepsis and use of nephrotoxic substances in generalized linear models. Table 1 ). The distribution of age category, diabetes, cancer, primary admission diagnosis, sepsis and use of contrast agents for CT scans significantly varied across seasons. The most common admission diagnosis category of these patients with AKI was cardiovascular disease (nearly 30%), followed by pulmonary disease, gastrointestinal disease, genitourinary disease and injury (Supplementary data, Table S2 shows a list of more specific diagnoses in each category). Among patients with AKI, 61.4% satisfied the definition of AKI on the day of admission (post-admission Day 0), while 23.2% satisfied the definition on post-admission Days 1 to 6 and 15.4% satisfied the definition on Day 7 or later. The prevalence of sepsis was 20.7%, 25.1% and 50.8% among patients with AKI identified on post-admission Day 0, Days 1-6 and Day 7 or later, respectively.
R E S U L T S
Patient characteristics
Crude incidence of AKI
Clear seasonality was observed in both the number and proportion of patients with AKI among hospitalized patients ( Figure 1 ). Throughout the 3 years, the proportion of patients with AKI was highest in January (16.7%) and lowest in June (13.4%).
In a subgroup analysis by the five most common admission diagnosis categories of the patients with AKI, prominent seasonality was found for AKI associated with cardiovascular and pulmonary diseases, which were more common in winter (Figure 2 ). Subgroup analysis by the timing of AKI diagnosis showed clear seasonality of AKI diagnosed on post-admission Day 0, while seasonality was less clear for AKI diagnosed on Days 1-6 and seemingly absent for AKI diagnosed on Day 7 or later ( Figure 3 ). Patients in the oldest age group (!85 years old) showed the largest seasonal variation in the AKI incidence, and the seasonal variation diminished as the age decreased ( Figure 4 ).
Adjusted incidence of AKI
The adjusted odds ratios (ORs) were generally smaller than the unadjusted ORs between the month of hospital admission and the incidence of AKI (Supplementary data, Table S3 ). However, the adjusted ORs suggest an independent association between the month of hospital admission and the incidence of AKI among hospitalized patients ( Figure 5 ). Compared with June as the reference month, the adjusted OR was highest in January at 1.24 [95% confidence interval (CI) 1.17-1.31].
Disease severity and 30-day mortality of patients with AKI
The distribution of AKI stages significantly varied across seasons, with the proportions of patients with more severe AKI stages being lower in summer and higher in winter ( Defined on the day of AKI diagnosis as (i) pulmonary: PaO 2 /FiO 2 ratio of <300 mmHg or use of a mechanical ventilator, (ii) haematological: platelet count of 100 000/lL, (iii) hepatic: serum total bilirubin level of !4.0 mg/dL, (iv) cardiovascular: systolic blood pressure of <90 mmHg, mean arterial pressure of <70 mmHg, systolic blood pressure decrease of >40 mmHg or use of vasoactive drugs, and (v) neurological: altered mental status, defined in this study as a Japanese Coma Scale score of 10 or worse.
b Adjusted for age, sex, year of admission, comorbidities (hypertension, diabetes mellitus, chronic kidney disease, liver disease and cancer), admission diagnosis category (cardiovascular disease, pulmonary disease, abdominal disease, genitourinary disease, injury and others), sepsis and use of nephrotoxic substances (contrast agents for CT scans, angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, diuretics, non-steroidal anti-inflammatory drugs, aminoglycosides, vancomycin, amphotericin B and cisplatin). that patient characteristics, known AKI risk factors and other failing organs partly explained the association between season and 30-day mortality. However, there remained an independent association between season and 30-day mortality among patients with AKI.
Sensitivity analysis
By assuming that patients with unavailable previous serum creatinine records (34.2% of the study population) had baseline kidney function corresponding to the best serum creatinine value during hospitalization, the number of patients with AKI decreased to 63 969 (11.5% of the 555 940 hospitalized patients). However, the seasonality of the AKI incidence, disease severity and 30-day mortality remained similar (Supplementary data, Table S4 , Figures S1-S5 and Table S5 ).
Additional analysis
The adjusted OR (AKI versus non-AKI) for 30-day mortality was not substantially different across seasons, as indicated by large overlaps in the 95% CIs in each admission diagnosis category (Supplementary data, Table S6 ). This suggests that the impact of AKI on 30-day mortality may not vary widely across seasons.
D I S C U S S I O N
Using data from 38 Japanese community hospitals in the large Tokushukai Medical Database, we found that the incidence of AKI among hospitalized patients was higher in winter. Our subgroup analyses suggest that the seasonality of the AKI incidence was driven by community-acquired AKI (diagnosed on postadmission Day 0) associated with the admission diagnosis of cardiovascular and pulmonary diseases among older patients. However, further analysis suggested that an independent association was also present between season and incidence of AKI among hospitalized patients. Patients with AKI in winter reached more severe AKI stages and had more severe disease conditions, including the presence of pulmonary, cardiovascular and neurological organ failure, and their 30-day mortality was higher.
To our knowledge, this is the first study to examine seasonal variation in the incidence of AKI among hospitalized patients. As previously suggested, AKI most often occurs in the context of acute illnesses such as heart disease and infection (e.g. pneumonia) rather than as the primary reason for hospitalization [12, 13] . Therefore, it may be reasonable to assume that the seasonality of AKI is largely influenced by the seasonality of underlying acute illnesses associated with AKI. Indeed, a previous Japanese study showed that cardiovascular and respiratory diseases, the predominant underlying conditions leading to AKI in the current study, increased in winter [24] .
In the analytical part of our study, the adjusted ORs were generally smaller than the unadjusted ORs between the month of hospital admission and the incidence of AKI, suggesting that patient characteristics and known AKI risk factors (including the primary admission diagnosis) were responsible for part of the association between season and AKI. However, an independent association between the month of hospital admission and the incidence of AKI persisted after adjustment for the covariates. One potential explanation for this finding is that seasonal variations in weather conditions (e.g. temperature, humidity) may influence the susceptibility to AKI.
Disease severity and mortality of patients with AKI were also worse in winter. In line with the increased number of patients with AKI associated with primary diagnoses of cardiovascular and pulmonary diseases, the proportions of patients with cardiovascular and pulmonary organ failure were higher in winter. The distribution of AKI stages (based on the worst serum creatinine value during hospitalization) was slightly but significantly worse in winter as indicated by higher proportions of patients with more severe stages. Together with the higher mortality in patients with AKI in winter, this suggests that patients develop more severe and irreversible forms of AKI in winter. The severe consequences of AKI are most likely due to the characteristics of acute illnesses associated with AKI in winter [25] . However, it is also possible that physiological responses to cold temperatures in winter, such as already-activated sympathetic nerves and vasoconstriction [26] , may hinder recovery of kidney function.
Our findings have important clinical implications. First, considering that the number and proportion of patients with the most severe AKI requiring RRT were largest in winter, hospitals may need to improve their ability to support the expected increase in demand for acute dialysis care during winter with necessary equipment and staffing. Secondly, the physician in charge should be aware that patients with AKI admitted in winter can be more critically ill and should thus seek consultation from specialists as needed. Finally, from a public health viewpoint, better outpatient-based management of cardiovascular and pulmonary diseases may contribute to a reduction in the AKI incidence in winter. For example, exacerbations of heart failure may be prevented by the adherence to prescription drugs and dietary salt restriction [27] , and flu and pneumococcal vaccinations may help to prevent respiratory infections [28] . Although many people anecdotally believe that avoiding dehydration is the most effective way to prevent AKI, the best approach to reduce the incidence of AKI probably differs depending on the season.
The main strength of our study is the large sample of patients obtained from 38 community hospitals across Japan. However, several limitations must be acknowledged. First, because of the lack of urine volume records in the database, the definition of AKI was based on the KDIGO serum creatinine criterion [10] . In addition, imputed serum creatinine values were used as surrogates for baseline kidney function of approximately one-third of the hospitalized patients because of the lack of previous serum creatinine records. Therefore, misclassification of the AKI status is possible. However, we believe that any misclassifications of the AKI status were independent of the season and therefore did not affect our observations of the seasonal fluctuation of the AKI incidence and mortality. Moreover, we used two different imputation methods (i.e. assuming baseline kidney function corresponding to a GFR of 75 mL/min/1.73 m 2 and the best serum creatinine value during hospitalization) to confirm that the seasonality of AKI was similarly observed. Second, the cause of AKI was not uniformly recorded in the database. Therefore, with reference to previous studies on AKI using administrative databases [12, 13] , we classified patients with AKI by the primary admission diagnosis category, assuming that the main trigger for AKI was the disease that resulted in hospital admission. However, multiple conditions (e.g. respiratory infection and dehydration) might have been present in a single patient at admission, and the ICD-10 code assignment for the admission diagnosis might have varied among attending physicians. Furthermore, we were unable to collect more specific information regarding the etiological classification of AKI, such as urine biomarkers and fractional excretion of sodium. These unmeasured factors or residual confounding (e.g. severity of underlying acute illnesses associated with AKI) may explain the remaining association between season and AKI. Therefore, more accurate identification of the causes of AKI is warranted in future studies to explain the seasonality of the AKI incidence in more detail. Third, we followed a recent large international study of AKI to define failing organs associated with AKI [19] , but we found that the dichotomization of each organ failure status by a single parameter (e.g. serum total bilirubin for hepatic failure) might cause some misclassification. Fourth, our findings may not be generalizable to regions with different climate patterns. Most regions of Japan belong to the temperate zone and have distinct seasonal patterns with regard to temperature and rainfall [29] . Provided that our observation of AKI seasonality can be ascribed to variations in temperature and humidity, countries or regions with a relatively constant temperature and humidity may not observe any seasonal variation in the incidence of AKI.
In conclusion, this large Japanese study demonstrated that AKI is more common among hospitalized patients and that patients with AKI are more severely ill in winter. Greater awareness of AKI seasonality would help to improve clinical practice, hospital resource utilization and community-based preventive care.
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